EMEA-003622-PIP01-24 - paediatric investigation plan

inobrodib

Key facts

• Active Substance:
  inobrodib
• Therapeutic area:
  Neoplasms benign, malignant and unspecified (incl cysts and polyps)
• Decision number:
  P/0287/2024
• PIP number:
  EMEA-003622-PIP01-24
• Pharmaceutical form(s):
  All pharmaceutical forms
• Condition(s) / indication(s):
  Treatment of Multiple Myeloma
• Route(s) of administration:
  All routes of administration
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  16/08/2024

Decision

P/0287/2024 : EMA decision of on the granting of a product-specific waiver for inobrodib (EMEA-003622-PIP01-24)

AdoptedReference Number: EMA/344293/2024